- HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation
-
Ahn S, Woo JW, Lee K, Park SY
- KMID: 2501593
- J Pathol Transl Med.
- 2020 Jan;54(1):34-44.
- doi: 10.4132/jptm.2019.11.03
Human epidermal growth factor receptor 2 (HER2) protein overexpression and/or HER2 gene amplification is found in about 20% of invasive breast cancers. It is a sole predictive marker for treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinicopathologic Implications of ALK Gene Copy Number Gain in Non-small Cell Lung Cancer
-
Yoo SB, Kim H, Xu X, Sun PL, Jin Y, Paik JH, Jheon S, Lee CT, Chung JH
- KMID: 2005739
- J Lung Cancer.
- 2011 Dec;10(2):87-93.
- doi: 10.6058/jlc.2011.10.2.87
PURPOSE: The anaplastic lymphoma kinase (ALK) gene is a potential molecular target in non-small cell lung carcinoma (NSCLC). The clinicopathologic implication of a change in the ALK gene copy number... -
- CITED
-
- Close
- SHARE
-
- Close
